INTRODUCTION
A breast physician is a medical practitioner with special training in the diagnosis and management of breast disease. This relatively small group of specialized clinicians has a unique and constantly expanding role in multidisciplinary breast teams in Korea. The importance of the team approach is well-known and in the field of breast cancer there is evidence that patients cared for by a multidisciplinary team (MDT) rather than a series of individual practitioners have an improved survival 10 years following diagnosis [1] . National and international clinical practice guidelines [2] endorse multidisciplinary care as the preferred approach to manage breast cancer. However, few studies have looked at how these guidelines are followed by the medical community. Also, the definition of MDT varies both in the literature [3, 4] and among health professionals, with no one interpretation being a perfect fit for all situations.
A recent report [3] described that surgery, chemotherapy and hormonal therapy are the most common treatment options for women, thus requiring input from a However, the outcomes of the MDT approach have not been rigorously evaluated and evidence from published empirical studies and reports on any benefit is limited [4, 5] .
This study aimed to assess the current workings of MDT meetings throughout Korea through surgeons' reports and their current commitments to MDT breast meetings, and to determine any perceived areas where there was potential for improvement.
METHODS
A questionnaire was sent out to 307 members of The 
RESULTS

Responder analysis
About 21% (65/307) of KBCS members who were contacted completed and returned the survey. Forty-nine of the 90 institutions (52.1%) that were contacted participated in this survey. Most responders were male (48/65) and worked at hospitals with more than 500 beds (54/65).
Fifty-seven of 65 responders (88%) belonged to the Department of Surgery, one to the Department of Medical
Oncology, and seven to other departments. Forty-eight responders (75%) had more than 5 years experience in managing breast cancer patients ( Table 1) .
Subject of follow-up management
Most commonly (95%), follow-up involved the Department of Surgery with or without adjuvant chemotherapy.
When adjuvant chemotherapy was included, surgeon fol-thesurgery.or.kr low-up occurred in 76% of the cases. Ninety-five percent of patients receiving hormonal therapy were followed up at the Department of Surgery (Table 2) .
MDT approach
Thirty-eight of the 61 responders (62.3%) participated in MDT meetings. Of these, 23 responders (37.7%) had not participated in MDT meetings, but felt that the approach was valuable and necessary for improved patient care (Fig. 1A) .
Concerning team structure, most MDTs consisted of breast surgeons, medical oncologists, radiologists, pathologists and radiation oncologists. A few teams also included psychiatrists and other support members (Fig. 1B) .
The largest number of responders (94.7%) reported that the MDT leader was a breast surgeon (Fig. 1C) .
A relatively even distribution was evident in the responses concerning the frequency of MDT meetings. Of the 38 MDT meeting participants, 13 attended more than one meeting a week, with the meeting schedule being irregular for seven respondents (Fig. 1D ). Almost all newly diagnosed patients, most postoperative patients and recurring cases were discussed in MDT meetings and a small number of patients with benign disease were discussed ( Fig. 2A) . The discussion of pathology results, radiologic review of disease, surgical findings and appropriate treatment plan were almost always part of a case discussion (Fig. 2B) . In comparison, relevant psychosocial issues were discussed in only 2.1% of the meetings. given that international audits of MDT functionality consistently reveal that medical oncologists are least likely to attend the meetings, of all medical specialists [6, 7] . This is not surprising, however, given that most oncologists in our sample were based in comprehensive or university thesurgery.or.kr cancer centers where oncology services are most commonly available.
Presently, the presence of psychologists in MDTs was limited despite clinical practice guidelines [2] highlighting the importance of psychosocial care for cancer patients and the well-documented elevated levels of psychosocial morbidity and unmet emotional and supportive care needs associated with diagnosis and treatment of breast cancer [8, 9] . Also, there was a low level of participation by
other support personnel such as data managers, coordinators and social workers. Psychosocial issues were not discussed in the majority of responses, yet it is not possible to tell from this data whether links to psychosocial services were in place outside of the meeting.
All newly diagnosed breast cancer patients were discussed in 45% of MDT meetings, a figure less than 60 to 94% noted in studies from the United Kingdom [6, 7] .
Discussion of benign cases was infrequent (8% of cases). cancer patients and patients with benign disease who require surgery [10] .
In conclusion, the majority of health professionals regard MDT meetings as an effective method for treatment planning and a relatively active MDT approach exists in most major centers in Korea. Further work is needed to ensure that MDTs function and co-operate as intended, and that all breast cancer patients have access to an MDT.
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